David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.77% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Maravai LifeSciences
MRVI
$1.34B
| $8.07M | 0.01% |
1,232,499
+463,246
| +60% | +$2.99M |
|
1402
Granite Construction
GVA
$5.42B
| $8.07M | 0.01% |
158,669
+95,068
| +149% | +$4.15M |
|
1403
Tanger
SKT
$4.42B
| $8.07M | 0.01% |
291,072
-13,965
| -5% | -$348K |
|
|
WCC
1404
CALL
WESCO International
WCC
$16.5B
| $8.07M | 0.01% |
46,400
-10,000
| -18% | -$1.5M |
|
1405
CALL
Equinix
EQIX
$106B
| $8.05M | 0.01% |
10,000
| – | – |
|
1406
Amylyx Pharmaceuticals
AMLX
$4.17B
| $8.05M | 0.01% |
546,965
-213,325
| -28% | -$3.27M |
|
1407
Suncor Energy
SU
$76.4B
| $8.03M | 0.01% |
250,608
-666,686
| -73% | -$21.8M |
|
|
JBGS
1408
JBG SMITH
JBGS
$741M
| $8.02M | 0.01% |
471,353
+131,567
| +39% | +$1.92M |
|
1409
PUT
Synchrony
SYF
$26.3B
| $8.01M | 0.01% |
+209,800
| New | +$6.64M |
|
1410
RxSight
RXST
$266M
| $8.01M | 0.01% |
198,570
+110,283
| +125% | +$3.23M |
|
1411
Atkore
ATKR
$3.16B
| $8.01M | 0.01% |
50,034
-40,867
| -45% | -$5.64M |
|
1412
AGCO
AGCO
$7.77B
| $8M | 0.01% |
65,893
-31,451
| -32% | -$3.68M |
|
1413
CALL
Domino's
DPZ
$11.6B
| $8M | 0.01% |
19,400
+600
| +3% | +$225K |
|
|
INFA
1414
DELISTED
Informatica
INFA
| $8M | 0.01% |
281,646
+241,634
| +604% | +$5.81M |
|
1415
Nasdaq
NDAQ
$55.2B
| $7.99M | 0.01% |
137,485
+54,041
| +65% | +$2.85M |
|
|
PLL
1416
CALL
DELISTED
Piedmont Lithium
PLL
| $7.98M | 0.01% |
282,800
+260,400
| +1,163% | +$7.65M |
|
1417
Matsons
MATX
$6.66B
| $7.98M | 0.01% |
72,838
+38,064
| +109% | +$3.61M |
|
1418
CALL
Shake Shack
SHAK
$2.99B
| $7.98M | 0.01% |
107,700
+44,200
| +70% | +$2.71M |
|
1419
CALL
Madrigal Pharmaceuticals
MDGL
$11.8B
| $7.98M | 0.01% |
34,500
+10,000
| +41% | +$1.75M |
|
1420
PUT
Oshkosh
OSK
$9.58B
| $7.98M | 0.01% |
73,600
+55,900
| +316% | +$5.41M |
|
1421
CALL
Apollo Global Management
APO
$78.6B
| $7.96M | 0.01% |
85,400
| – | – |
|
1422
Sonoco
SON
$5.72B
| $7.96M | 0.01% |
142,427
-6,070
| -4% | -$329K |
|
|
NVEI
1423
CALL
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $7.95M | 0.01% |
302,600
+195,900
| +184% | +$3.76M |
|
1424
Pulmonx
LUNG
$107M
| $7.94M | 0.01% |
622,588
-45,770
| -7% | -$477K |
|
|
FFWM
1425
DELISTED
First Foundation Inc
FFWM
| $7.94M | 0.01% |
819,750
+35,739
| +5% | +$228K |
|
Similar funds
David Shaw's Q4 2023 Portfolio in Review
As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
- David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- David Shaw opened 575 new positions and closed 527 in Q4 2023.
- David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.